Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Journal of Translational Medicine|May 19, 2026
Role of Bladder EpiCheck® in Bladder cancer: from primary diagnosis to surveillanceMarcel Figueras, Mercedes Ingelmo-Torres, Fiorella L Roldan, et al.European Urology|May 20, 2008
Molecular lymph node staging in bladder urothelial carcinoma: impact on survivalMercedes Marín-Aguilera, Lourdes Mengual, Moisès Burset, et al.International Journal of Molecular Sciences|October 14, 2022
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder CancerRaquel Carrasco, Mercedes Ingelmo-Torres, Ascensión Gómez, et al.BJU International|November 5, 2013
Prognostic value of microRNA expression pattern in upper tract urothelial carcinomaLaura Izquierdo, Mercedes Ingelmo-Torres, Carmen Mallofré, et al.Cancers|December 24, 2021
Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell CarcinomaFiorella L Roldán, Juan J Lozano, Mercedes Ingelmo-Torres, et al.Diagnostics (Basel, Switzerland)|October 25, 2024
Role of Liquid Biopsy in Progressive PSA Patients after Radical ProstatectomyMarcel Figueras, Lourdes Mengual, Mercedes Ingelmo-Torres, et al.Scientific Reports|March 18, 2021
Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implicationRaquel Carrasco, Laura Izquierdo, Antoine G van der Heijden, et al.International Journal of Molecular Sciences|April 13, 2024
Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial CarcinomaBernat Padullés, Raquel Carrasco, Mercedes Ingelmo-Torres, et al.BJU International|March 6, 2025
Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancerFiorella L Roldán, Mercedes Ingelmo-Torres, Claudia Mercader, et al.European Urology|February 8, 2011
MicroRNA in prostate, bladder, and kidney cancer: a systematic reviewJames W F Catto, Antonio Alcaraz, Anders S Bjartell, et al.Pageof 8